If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

Share Price is delayed by 15 minutes
Get Live Data
451.20    1.20 (0.27%)
Bid:
448.40
Ask:
449.20
Spread: 0.80 (0.178%)
Market Cap: £1.11b
VSVS Live PriceLast checked at - London Stock Exchange

Intraday Vesuvius Share Chart

Directorate Change

27 Nov 2012 07:00

RNS Number : 0497S
Cookson Group PLC
27 November 2012
 



 

27 November 2012

Appointment of Finance Director of Alent plc

 

Cookson Group plc ("Cookson") announced on 1 November 2012 that the Performance Materials division is to be demerged to form a new London listed specialty chemicals company, Alent plc ("Alent"). These proposals were approved by the Court Meeting and the General Meeting of Cookson Shareholders on 26 November 2012 and the demerger is expected to become effective on 19 December 2012.

 

Cookson announces today that David Egan will become Finance Director of Alent with effect from 1 January 2013. 

 

Mr Egan is currently the Chief Financial Officer at ESAB, which was the largest division of Charter International plc which was itself acquired by Colfax Corporation in 2012.

 

Prior to joining ESAB in 2008, Mr Egan was Group Financial Controller of Hanson plc based in London, and prior to that Chief Financial Officer, Hanson Asia Pacific based in Singapore. He has extensive international experience of businesses in Europe, including the Russian Federation, Asia, Australasia, and the Americas.

 

Mr Egan is a qualified Certified Practicing Accountant (CPA), Australia and is a dual British and Australian citizen.

 

Peter Hill, Chairman designate of Alent, said:

 

"I look forward to welcoming David, with his wealth of experience in senior and international finance roles, to Alent's board. His appointment completes the line-up of what I believe will be a strong and experienced Board, with the depth and mix of skills to maximise the opportunities for Alent and its shareholders, as a stand-alone company."

 

As previously announced, Mike Butterworth, currently Group Finance Director of Cookson, will act as Interim Finance Director for Alent from listing until 1 January 2013.

 

No disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority's Listing Rules in respect of this appointment.

 

Ends

 

For further information please contact:

 

Shareholder/Analyst Enquiries:

 

Steve Corbett, Chief Executive designate, Alent plc

Mike Butterworth, Interim Finance Director, Alent plc

 

+44 (0)20 7822 0064

Frances Gibbons, Investor Relations Manager, Alent plc

 

+44 (0) 7850 880868

fgibbons@cookson.com

 

Media Enquiries:

 

John Olsen/Ian Payne

MHP Communications

 

+44 (0)20 3128 8100

 

 

About Alent plc:

 

Alent will comprise what is currently the Performance Materials division of Cookson, a leading global supplier of advanced surface treatment plating chemicals and electronics assembly materials.

 

Alent's principal end-market is global electronics production, accounting for approximately three quarters of revenue, with the other quarter represented by the automotive and other industrial markets.

 

Alent will be organised into two business segments:

 

·; Assembly Materials, trading as Alpha and supplying electronic interconnect materials to assemblers of printed circuit boards (PCBs) and the semiconductor packaging industry

 

·; Surface Chemistries, trading as Enthone and supplying specialty electroplating chemicals and services for use in semiconductors and PCB fabrication, as well as corrosion resistant/decorative coatings for various industries, particularly the automotive industry.

 

Alent had net sales value of £418 million and an adjusted trading profit of £96 million in the year ended 31 December 2011. The net sales value was split broadly one third in each of Europe, Asia and the Americas.

 

Alent is present in over 100 countries and has over 2,500 employees and 23 manufacturing sites worldwide. This enables Alent to supply its customers with highly engineered and customised specialty chemicals and materials on a just in time basis from its strategic locations around the world.

 

Alent's Board will comprise:

 

Peter Hill CBE Non-Executive Chairman

Steve Corbett Chief Executive

David Egan Finance Director

Dr Emma FitzGerald Non-Executive

Lars Förberg Non-Executive

Noël Harwerth Non-Executive; Chairman of the Remuneration Committee

Jan Oosterveld Non-Executive

Mark Williamson Non-Executive; Senior Independent Director; Chairman of Audit Committee

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVQLFLLFFLFBX
Date   Source Headline
29th May 20265:11 pmPRNDirectorate change - interim Remuneration Committee Chair
28th May 20264:09 pmPRNNotice of Results
28th May 20267:00 amPRNTrading statement
1st May 202610:40 amPRNTotal Voting Rights
14th Apr 20266:21 pmPRNDirector/PDMR Shareholding
14th Apr 20266:19 pmPRNDirector/PDMR Shareholding
9th Apr 20263:06 pmPRNAnnual Financial Report
8th Apr 20265:03 pmPRNDirector/PDMR Shareholding
16th Mar 20261:18 pmRNSDirectorate change
16th Mar 20261:18 pmPRNDirectorate change
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
11th Mar 202612:17 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:01 pmPRNTotal Voting Rights
13th Nov 20257:00 amPRNAcquisition
11th Nov 20257:00 amPRNTrading Statement
3rd Oct 20253:52 pmPRNDirector/PDMR Shareholding
25th Sep 20255:01 pmPRNDirector/PDMR Shareholding
22nd Aug 20258:00 amPRNAcquisition of the Molten Metal Systems business from Morgan Advanced Materials Plc
6th Aug 20257:00 amRNSHalf-year Report
24th Jul 20257:00 amPRNTrading Statement
11th Jun 20254:07 pmPRNDirector/PDMR Shareholding
2nd Jun 20253:15 pmPRNTotal Voting Rights
16th May 20252:58 pmPRNResult of AGM
16th May 20257:00 amPRNTrading Statement
1st May 20259:21 amPRNTotal Voting Rights
29th Apr 20255:05 pmPRNDirector/PDMR Shareholding
9th Apr 20254:59 pmPRNDirector/PDMR Shareholding
9th Apr 20254:58 pmPRNDirector/PDMR Shareholding
8th Apr 20255:14 pmPRNDirector/PDMR Shareholding
8th Apr 20255:13 pmPRNDirector/PDMR Shareholding
8th Apr 20253:53 pmPRNAnnual Financial Report
3rd Apr 202512:20 pmPRNHolding(s) in Company
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202510:56 amPRNTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 202511:02 amPRNDirector Declaration
18th Mar 20255:35 pmPRNDirector/PDMR Shareholding
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20252:48 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.